THC in follicular fluid linked to lower embryo quality and chromosome errors in fertility patients

In the clinical study, follicular fluid THC concentration was positively correlated with oocyte maturation, but THC-positive patients had significantly lower embryo euploid (chromosomally normal) rates than matched controls. In the lab, THC induced oocyte chromosome segregation errors, increased abnormal spindle morphology, and altered expression of genes involved in extracellular matrix remodeling, inflammation, and chromosome segregation.

Two-pronged approach: (1) Case-control study comparing fertility patients who tested positive for THC in follicular fluid with matched controls, examining oocyte maturation and embryo euploidy rates. (2) In vitro experiments exposing human oocytes to THC and measuring chromosome segregation, spindle morphology, and gene expression. Published in Nature Communications.

This is the first study to directly examine THC's effects on human oocytes (eggs). The finding that THC causes chromosome segregation errors provides a biological mechanism for reduced fertility and potentially increased risk of chromosomally abnormal pregnancies in cannabis users.

While extensive research has examined THC's effects on sperm, this is the first comparable investigation for oocytes. The paradox of increased oocyte maturation but decreased embryo quality suggests THC may accelerate maturation in a way that compromises subsequent development, a pattern seen with other reproductive toxicants. Published in Nature Communications, this carries significant scientific weight.

The clinical component is a case-control study, not a randomized trial. THC exposure in the lab may not replicate the complexity of in vivo exposure. The sample size for the clinical study was not detailed in the abstract. Follicular fluid THC levels may not reflect chronic exposure patterns.